40.40 - 41.05
29.80 - 47.18
2.12M / 3.66M (Avg.)
18.02 | 2.27
Helps investors judge whether earnings growth is driven by sustainable operations or temporary factors. Consistent, organic income expansion can justify a higher intrinsic value for patient, long-term investors.
411.79%
Positive growth while VET shows revenue decline. John Neff would investigate competitive advantages.
130.42%
Cost increase while VET reduces costs. John Neff would investigate competitive disadvantage.
109.76%
Positive growth while VET shows decline. John Neff would investigate competitive advantages.
167.28%
Margin expansion exceeding 1.5x VET's 1.83%. David Dodd would verify competitive advantages.
No Data
No Data available this quarter, please select a different quarter.
-35.43%
G&A reduction while VET shows 16.70% growth. Joel Greenblatt would examine efficiency advantage.
No Data
No Data available this quarter, please select a different quarter.
-15.36%
Other expenses reduction while VET shows 0.00% growth. Joel Greenblatt would examine efficiency.
-18.14%
Operating expenses reduction while VET shows 33.57% growth. Joel Greenblatt would examine advantage.
196.53%
Total costs growth above 1.5x VET's 8.88%. Michael Burry would check for inefficiency.
-29.73%
Both companies reducing interest expense. Martin Whitman would check industry trends.
6.81%
D&A growth above 1.5x VET's 0.34%. Michael Burry would check for excessive investment.
128.42%
EBITDA growth while VET declines. John Neff would investigate advantages.
172.25%
EBITDA margin growth while VET declines. John Neff would investigate advantages.
390.41%
Operating income growth while VET declines. John Neff would investigate advantages.
257.29%
Operating margin growth while VET declines. John Neff would investigate advantages.
-47.73%
Other expenses reduction while VET shows 61.37% growth. Joel Greenblatt would examine advantage.
482.07%
Pre-tax income growth exceeding 1.5x VET's 3.27%. David Dodd would verify competitive advantages.
286.69%
Pre-tax margin growth exceeding 1.5x VET's 9.95%. David Dodd would verify competitive advantages.
259.27%
Tax expense growth above 1.5x VET's 95.60%. Michael Burry would check for concerning trends.
134.28%
Net income growth while VET declines. John Neff would investigate advantages.
175.14%
Net margin growth while VET declines. John Neff would investigate advantages.
135.22%
EPS growth while VET declines. John Neff would investigate advantages.
131.68%
Diluted EPS growth while VET declines. John Neff would investigate advantages.
-1.53%
Share count reduction while VET shows 0.00% change. Joel Greenblatt would examine strategy.
-1.26%
Both companies reducing diluted shares. Martin Whitman would check patterns.
